Holen Sie sich die Stockscreener-App
0.24
2.13%
0.005
Schlusskurs vom Vortag:
$0.235
Offen:
$0.2295
24-Stunden-Volumen:
9.74M
Relative Volume:
2.05
Marktkapitalisierung:
$11.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-28.54M
KGV:
-0.375
EPS:
-0.64
Netto-Cashflow:
$-22.72M
1W Leistung:
-87.56%
1M Leistung:
-87.17%
6M Leistung:
-85.71%
1J Leistung:
-95.63%
1-Tages-Spanne:
$0.2251
$0.2577
1-Wochen-Bereich:
$0.2222
$0.825
52-Wochen-Spanne:
$0.2222
$7.88
Essa Pharma Inc Stock (EPIX) Company Profile
Firmenname
Essa Pharma Inc
Sektor
Branche
Telefon
(778) 331-0962
Adresse
SUITE 720, VANCOUVER, BC
Vergleichen Sie EPIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
0.24 | 11.12M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-04 | Herabstufung | Jefferies | Buy → Hold |
| 2024-11-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-11-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-03-04 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-02 | Eingeleitet | Jefferies | Buy |
| 2019-10-25 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Essa Pharma Inc Aktie (EPIX) Neueste Nachrichten
What makes ESSA Pharma Inc. stock price move sharply2025 Risk Factors & Reliable Momentum Entry Alerts - Newser
What high frequency data says about ESSA Pharma Inc.Portfolio Update Report & Verified Momentum Watchlists - Newser
Will ESSA Pharma Inc. continue its uptrendMarket Risk Report & Verified Technical Trade Signals - Newser
Is ESSA Pharma Inc. still worth holding after the dipDollar Strength & Consistent Growth Equity Picks - Newser
Real time pattern detection on ESSA Pharma Inc. stockQuarterly Market Review & Long-Term Growth Portfolio Plans - Newser
Why ESSA Pharma Inc. is moving todayOptions Play & High Win Rate Trade Alerts - Newser
Technical analysis overview for ESSA Pharma Inc. stock2025 Bull vs Bear & Free Long-Term Investment Growth Plans - Newser
Price action breakdown for ESSA Pharma Inc.Weekly Trade Analysis & Low Drawdown Momentum Ideas - Newser
Will ESSA Pharma Inc. see short term momentum2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Order flow analysis tools used on ESSA Pharma Inc.July 2025 Summary & Low Drawdown Trading Strategies - Newser
ESSA Pharma Inc. stock volume spike explainedEntry Point & Long-Term Safe Return Strategies - Newser
Is ESSA Pharma Inc. still a buy after recent gainsJuly 2025 Market Mood & Daily Profit Maximizing Trade Tips - sundaytimes.kr
How to build a custom watchlist for ESSA Pharma Inc.Trade Exit Summary & Weekly High Potential Alerts - Newser
Published on: 2025-08-30 16:51:48 - Newser
ESSA Pharma Inc. stock trend outlook and recovery pathWeekly Investment Report & AI Enhanced Trade Execution Alerts - Newser
Does ESSA Pharma Inc. have a sustainable dividendJuly 2025 PreEarnings & Free Long-Term Investment Growth Plans - sundaytimes.kr
Chart based analysis of ESSA Pharma Inc. trendsWeekly Profit Analysis & Trade Opportunity Analysis Reports - Newser
Is ESSA Pharma Inc. stock bottoming outMarket Growth Report & Stepwise Entry/Exit Trade Alerts - Newser
Using economic indicators to assess ESSA Pharma Inc. potential2025 Market Trends & Accurate Buy Signal Alerts - Newser
Visual analytics tools that track ESSA Pharma Inc. performanceTrade Performance Summary & Consistent Profit Focused Trading Strategies - Newser
Essa Pharma (EPIX) Nosedives 66% Ahead of Business Shutdown - MSN
Identifying reversal signals in ESSA Pharma Inc.Weekly Investment Recap & Step-by-Step Swing Trade Plans - Newser
Exit strategy if you’re trapped in ESSA Pharma Inc.July 2025 Price Swings & Reliable Breakout Forecasts - Newser
INVESTOR ALERT: Morris Kandinov LLP Investigating ESSA Pharma Inc. (EPIX) - Newsfile
Finanzdaten der Essa Pharma Inc-Aktie (EPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):